CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Prif Awdur: | Eva, Israt Ara Jannat |
---|---|
Awduron Eraill: | Rahman, Kazi Fatema |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
Brac University
2023
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/17764 |
Eitemau Tebyg
-
A review on CRISPR-Cas system based applications in Oncology
gan: Sadia, Mir
Cyhoeddwyd: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
gan: Maria, Amatul
Cyhoeddwyd: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
gan: Nwabunwanne, Eze Uchenna
Cyhoeddwyd: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
gan: Shaikat, Mahdi Mubin
Cyhoeddwyd: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
gan: Ullah, Mohammad
Cyhoeddwyd: (2023)